1.
Chinese Journal of Medical Instrumentation
;
(6): 670-673, 2021.
Artículo
en Chino
| WPRIM
| ID: wpr-922080
RESUMEN
On the basis of introducing FDA's regulatory measure and relevant requirement for life-cycle management of combination product, this paper aims to discuss corresponding countermeasure for supervision system construction in consideration of domestic drug-device combination product's current situation, in order to promote innovative development of relevant industries.